BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parriman M, Campolo A, Waller AP, Lacombe VA. Adverse Metabolic Effects of Diltiazem Treatment During Diabetic Cardiomyopathy. J Cardiovasc Pharmacol Ther 2019;24:193-203. [PMID: 30458627 DOI: 10.1177/1074248418808392] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Kępczyński Ł, Wcisło S, Korzeniewska-Dyl I, Połatyńska K, Gach A, Moczulski D. No evidence for change in expression of TBC1D1 and TBC1D4 genes in cultured human adipocytes stimulated by myokines and adipokines. Adipocyte 2021;10:153-9. [PMID: 33769190 DOI: 10.1080/21623945.2021.1900497] [Reference Citation Analysis]
2 Arafat M, Sarfraz M, Bostanudin MF, Esmaeil A, Salam A, AbuRuz S. In Vitro and In Vivo Evaluation of Oral Controlled Release Formulation of BCS Class I Drug Using Polymer Matrix System. Pharmaceuticals (Basel) 2021;14:929. [PMID: 34577629 DOI: 10.3390/ph14090929] [Reference Citation Analysis]